Home The Word Brain My Amedeo FAQ Privacy About   


Chinese Coaching

Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.


  Alzheimer's Disease

  Free Subscription


Articles published in Neurochem Res

Retrieve available abstracts of 60 articles:
HTML format



Single Articles


    December 2025
  1. LI X, Liu Y, Hu H, Li S, et al
    Targeting Liquid-Liquid Phase Separation and Autophagy in Alzheimer's Disease: Insights into Molecular Mechanisms and Therapeutic Potential.
    Neurochem Res. 2025;51:9.
    PubMed     Abstract available


    November 2025
  2. WANG M, Zeng Y, Jin Y, Wu J, et al
    Progress and Perspectives on the Estrogen-Microbiota-Brain Axis in Alzheimer's Disease.
    Neurochem Res. 2025;51:3.
    PubMed     Abstract available


    October 2025
  3. HOVEIZI E, Bijavi G, Parsa H
    Advancing Cell Therapy to Enhance Passive Avoidance Memory: Integrative Approaches Combining Neural-Like Cells and Rosmarinic Acid Through Behavioral, Molecular, and Histological Analyses.
    Neurochem Res. 2025;50:334.
    PubMed     Abstract available


  4. YANG T
    Molecular Mechanisms of EDC-Induced Alzheimer's Disease and of Traditional Chinese Medicine Active Substances in Treating AD and Antagonizing EDC-Induced Effects.
    Neurochem Res. 2025;50:319.
    PubMed     Abstract available


    September 2025
  5. TALIB M, Siddiqui N, Tripathi PN, Chaudhary A, et al
    Correction to: Ameliorative Role of Phosphodiesterase-5 (PDE-5) Inhibitor "Avanafil" Via Modulating cAMP & cGMP Pathway Against Alzheimer's Disease.
    Neurochem Res. 2025;50:289.
    PubMed    


    August 2025
  6. WANG S, Xu Z, Wang S, Peng Q, et al
    Alamandine Rescues Cognitive Impairment and Ameliorates Alzheimer's Disease-Like Neuropathology in APP/PS1 Mice.
    Neurochem Res. 2025;50:277.
    PubMed     Abstract available


  7. PARMAR P, Chauhan H, Modi P, Israni D, et al
    Pharmacological Evaluation and In-Silico Study of Sabinene as a Potential Anti-Alzheimer's Drug in AlCl(3)-Induced Rat Model via BACE-1 and GSK3beta Modulation.
    Neurochem Res. 2025;50:278.
    PubMed     Abstract available


  8. WANG XC, Wu GL, Cai HY, Chu CL, et al
    Jiao-Tai-Wan Improves Cognitive Impairment by Regulating Nrf2/ARE/HO-1 Signaling Pathway in APP/PS1 Mice.
    Neurochem Res. 2025;50:268.
    PubMed     Abstract available


  9. TALIB M, Siddiqui N, Tripathi PN, Chaudhary A, et al
    Ameliorative Role of Phosphodiesterase-5 (PDE-5) Inhibitor "Avanafil" via Modulating cAMP & cGMP Pathway Against Alzheimer's Disease.
    Neurochem Res. 2025;50:258.
    PubMed     Abstract available


    July 2025
  10. YU Q, Li L, Yu S, Han J, et al
    Mitochondrial Damage and Autophagy Dysregulation in Alzheimer's Disease: Mechanisms and Therapeutic Opportunities.
    Neurochem Res. 2025;50:251.
    PubMed     Abstract available


  11. AMIN SS, Qusti S, Al-Otaibi WA, AlMotwaa SM, et al
    Correction: The Neuroprotective Impact of Agomelatine in Preserving Brain Tissue Molecular Structure Against Alzheimer's Disease Etiology.
    Neurochem Res. 2025;50:246.
    PubMed    


    June 2025
  12. YE K, Zeng M, Zhang B, Hao F, et al
    Piper Kadsura Extract and its Bioactive Components Attenuates Abeta(25-35)-Induced Neurotoxicity by Modulating Glycolysis and Activating the SIRT1/PPARgamma/GLUT1 Axis.
    Neurochem Res. 2025;50:216.
    PubMed     Abstract available


  13. BAVAFA A, Meftahi GH, Pirzad Jahromi G
    Multidimensional Evaluation of the Streptozotocin-Induced Alzheimer's Model: Integrating Molecular, Histopathological, and Behavioral Correlates Over Time.
    Neurochem Res. 2025;50:214.
    PubMed     Abstract available


  14. QADIR H, Hussain SH, Ghaffar A, Shah FA, et al
    Targeting Fyn Kinase for Alleviation of Cognitive Impairment in Streptozocin-Induced Alzheimer's Disease in Mice by Loperamide; An Experimental and in Silico Analysis.
    Neurochem Res. 2025;50:212.
    PubMed    


  15. JUSTO AFO, Toscano ECB, Goncalves NG, Leite REP, et al
    Selective Vulnerability of Hippocampi for Nitric Oxide Synthases in Alzheimer's Disease Pathology and Cognitive Abilities.
    Neurochem Res. 2025;50:197.
    PubMed     Abstract available


  16. SHAJI V, Amrutha S, Pervaje R, Abhinand CS, et al
    Exploration of Asparagus racemosus Willd for Alzheimer's Disease Through Integrated Metabolomics and Network Pharmacology Analyses Targeting BACE1 Protein.
    Neurochem Res. 2025;50:190.
    PubMed     Abstract available


  17. AMIN S, Qusti S, Al-Otaibi WA, AlMotwaa SM, et al
    The Neuroprotective Impact of Agomelatine in Preserving Brain Tissue Molecular Structure Against Alzheimer's Disease Etiology.
    Neurochem Res. 2025;50:189.
    PubMed     Abstract available


  18. ZHOU Y, Diwu YC, Li YX, Zhang JY, et al
    Neuroprotective Effects of Tectoridin in H(2)O(2)-Induced Oxidative Stress and an Amyloid-Infused Rat Model of Alzheimer's Disease.
    Neurochem Res. 2025;50:179.
    PubMed     Abstract available


    May 2025
  19. LV X, Ye T, Yang W, Zhu Z, et al
    Weissella confusa Attenuates Cognitive Deficits in Alzheimer's Disease by Reducing Oxidative Stress Via the SIRT1/PGC-1alpha Signaling Pathway.
    Neurochem Res. 2025;50:175.
    PubMed     Abstract available


  20. KAUR A, Goel RK
    Modelling Epilepsy Associated Alzheimer's Disease Through Mitochondrial Complex-I Inhibition: Neurochemical and Therapeutic Perspectives.
    Neurochem Res. 2025;50:163.
    PubMed     Abstract available


  21. SUN YW, Lei XY, Lyu XY, Yin Y, et al
    Decoupling of Neurochemical and White Matter Microstructural Integrity in Posterior Cingulate Cortex Predicts Early Alzheimer's Disease Progression.
    Neurochem Res. 2025;50:159.
    PubMed     Abstract available


  22. HU Y, Liu Y, Zhu Q, Chen Y, et al
    Identification of Novel Biomarkers Related to Vesicle Trafficking in Alzheimer's Disease Using Bioinformatics Approaches.
    Neurochem Res. 2025;50:157.
    PubMed     Abstract available


    April 2025
  23. CHENG L, Meng X, Tian D, Zheng B, et al
    Targeting UAF1 Alleviate Neurotoxicity by Inhibiting APP/NLRP3 Axis-Mediated Pyroptosis and Apoptosis.
    Neurochem Res. 2025;50:135.
    PubMed     Abstract available


    March 2025
  24. CAO F, Zhang P, Chi Y, Wang Y, et al
    Celastrol Ameliorated Alzheimer's Disease in Mice by Enhancing TBX21/TREM2 Expression in Microglia and Inhibiting Tau Phosphorylation.
    Neurochem Res. 2025;50:126.
    PubMed     Abstract available


  25. ORDONEZ WOC, Palomino NV, Varela PEV, Martinez IB, et al
    Alkaloids from Caliphruria subedentata (Amaryllidaceae) as Regulators of AChE, BuChE, NMDA and GSK3 Activity: An In Vitro and In Silico Approach for Mimicking Alzheimer s Disease.
    Neurochem Res. 2025;50:116.
    PubMed     Abstract available


    February 2025
  26. WANG J, Meng X, Yang J, Tang Y, et al
    Improvements in Exercise for Alzheimer's Disease: Highlighting FGF21-Induced Cerebrovascular Protection.
    Neurochem Res. 2025;50:95.
    PubMed     Abstract available


    January 2025
  27. ATHARI SZ, Kazmi S, Vatandoust SM, Mahmoudi J, et al
    Varenicline Attenuates Memory Impairment in Amyloid-Beta-Induced Rat Model of Alzheimer's Disease.
    Neurochem Res. 2025;50:86.
    PubMed     Abstract available


  28. DA COSTA P, Schetinger MRC, Baldissarelli J, Reichert KP, et al
    Blackcurrant (Ribes nigrum L.) and Its Association with Donepezil Restore Cognitive Impairment, Suppress Oxidative Stress and Pro-inflammatory Responses, and Improve Purinergic Signaling in a Scopolamine-Induced Amnesia Model in Mice.
    Neurochem Res. 2025;50:79.
    PubMed     Abstract available


  29. LIU X, Lv Z, Huang Q, Lei Y, et al
    The Role of Oligodendrocyte Lineage Cells in the Pathogenesis of Alzheimer's Disease.
    Neurochem Res. 2025;50:72.
    PubMed     Abstract available


    December 2024
  30. SMAIL SW
    Targeting Neuroinflammation and Apoptosis: Cardamonin's Cognitive Benefits in Alzheimer's 5XFAD Mice.
    Neurochem Res. 2024;50:57.
    PubMed     Abstract available


  31. PASHAEI S, Shabani S, Mohammadi S, Morozova-Roche LA, et al
    Differential Expression of Neurodegeneration-Related Genes in SH-SY5Y Neuroblastoma Cells Under the Influence of Cyclophilin A: Could the Enzyme be a Likely Trigger and Therapeutic Target for Alzheimer's Disease?
    Neurochem Res. 2024;50:47.
    PubMed     Abstract available


    November 2024
  32. ARORA Y, Samkaria A, Maroon JC, Mandal PK, et al
    Longitudinal Monitoring of Glutathione Stability in Different Microenvironments.
    Neurochem Res. 2024;50:9.
    PubMed     Abstract available


    August 2024
  33. THENMOZHI AJ, Raja TRW, Janakiraman U, Manivasagam T, et al
    Retraction Note: Neuroprotective Effect of Hesperidin on Aluminium Chloride Induced Alzheimer's Disease in Wistar Rats.
    Neurochem Res. 2024 Aug 23. doi: 10.1007/s11064-024-04232.
    PubMed    


  34. COLIN-MARTINEZ E, Espino-de-la-Fuente C, Arias C
    Age- and Sex-Associated Wnt Signaling Dysregulation is Exacerbated from the Early Stages of Neuropathology in an Alzheimer's Disease Model.
    Neurochem Res. 2024 Aug 21. doi: 10.1007/s11064-024-04224.
    PubMed     Abstract available


    July 2024
  35. ASCHNER M, Skalny AV, Santamaria A, Rocha JBT, et al
    Epigenetic Mechanisms of Aluminum-Induced Neurotoxicity and Alzheimer's Disease: A Focus on Non-Coding RNAs.
    Neurochem Res. 2024 Jul 27. doi: 10.1007/s11064-024-04214.
    PubMed     Abstract available


  36. LI C, Zhao X, Xu H, Liu X, et al
    NMN Synbiotics: A Multifaceted Therapeutic Approach for Alzheimer's Disease.
    Neurochem Res. 2024 Jul 22. doi: 10.1007/s11064-024-04210.
    PubMed     Abstract available


  37. LUO JS, Zhai WH, Ding LL, Zhang XJ, et al
    MAMs and Mitochondrial Quality Control: Overview and Their Role in Alzheimer's Disease.
    Neurochem Res. 2024 Jul 13. doi: 10.1007/s11064-024-04205.
    PubMed     Abstract available


  38. LOPEZ HANOTTE J, Peralta F, Reggiani PC, Zappa Villar MF, et al
    Investigating the Impact of Intracerebroventricular Streptozotocin on Female Rats with and without Ovaries: Implications for Alzheimer's Disease.
    Neurochem Res. 2024 Jul 10. doi: 10.1007/s11064-024-04204.
    PubMed     Abstract available


  39. GAYGER-DIAS V, Menezes L, Da Silva VF, Stiborski A, et al
    Changes in Astroglial Water Flow in the Pre-amyloid Phase of the STZ Model of AD Dementia.
    Neurochem Res. 2024;49:1851-1862.
    PubMed     Abstract available


    June 2024
  40. OLIVEIRA-LIMA OC, de Carvalho GA, do Prado Assuncao L, Bailao AM, et al
    GlyT1 Inhibition by NFPS Promotes Neuroprotection in Amyloid-beta-Induced Alzheimer's Disease Animal Model.
    Neurochem Res. 2024 Jun 18. doi: 10.1007/s11064-024-04190.
    PubMed     Abstract available


  41. SHENG L, Bhalla R
    Biomarkers and Target-Specific Small-Molecule Drugs in Alzheimer's Diagnostic and Therapeutic Research: From Amyloidosis to Tauopathy.
    Neurochem Res. 2024 Jun 6. doi: 10.1007/s11064-024-04178.
    PubMed     Abstract available


  42. WANG XF, Xiang XH, Wei J, Zhang PB, et al
    Raddeanin A Protects the BRB Through Inhibiting Inflammation and Apoptosis in the Retina of Alzheimer's Disease.
    Neurochem Res. 2024 Jun 4. doi: 10.1007/s11064-024-04145.
    PubMed     Abstract available


    May 2024
  43. QIU NZ, Hou HM, Guo TY, Lv YL, et al
    Phosphodiesterase 8 (PDE8): Distribution and Cellular Expression and Association with Alzheimer's Disease.
    Neurochem Res. 2024 May 23. doi: 10.1007/s11064-024-04156.
    PubMed     Abstract available


  44. KUEDO Z, Binlateh T, Benjakul S, Hutamekalin P, et al
    Pretreatment with Liposome-Encapsulated Shrimp Shell Extract Attenuated Neuronal Damage and Death in Abeta(1-42)-Induced Memory Deficits in Rats.
    Neurochem Res. 2024;49:1166-1187.
    PubMed     Abstract available


    March 2024
  45. XIAO X, Rui Y, Jin Y, Chen M, et al
    Relationship of Sleep Disorder with Neurodegenerative and Psychiatric Diseases: An Updated Review.
    Neurochem Res. 2024;49:568-582.
    PubMed     Abstract available


    February 2024
  46. ZHANG LJ, Zhang HZ, Liu YW, Tang M, et al
    Sulphated Fucooligosaccharide from Sargassum Horneri: Structural Analysis and Anti-Alzheimer Activity.
    Neurochem Res. 2024 Feb 2. doi: 10.1007/s11064-024-04107.
    PubMed     Abstract available


  47. ALLNUTT MA, Matera KM
    Stabilization and Reduced Cytotoxicity of Amyloid Beta Aggregates in the Presence of Catechol Neurotransmitters.
    Neurochem Res. 2024;49:379-387.
    PubMed     Abstract available


  48. DHALIWAL N, Dhaliwal J, Chopra K
    7, 8-dihydroxyflavone Ameliorates Cholinergic Dysfunction, Inflammation, Oxidative Stress, and Apoptosis in a Rat Model of Vascular Dementia.
    Neurochem Res. 2024 Feb 1. doi: 10.1007/s11064-023-04090.
    PubMed     Abstract available


    January 2024
  49. LIU Y, Meng XK, Shao WZ, Liu YQ, et al
    miR-34a/TAN1/CREB Axis Engages in Alleviating Oligodendrocyte Trophic Factor-Induced Myelin Repair Function and Astrocyte-Dependent Neuroinflammation in the Early Stages of Alzheimer's Disease: The Anti-Neurodegenerative Effect of Treadmill Exercise.
    Neurochem Res. 2024 Jan 30. doi: 10.1007/s11064-024-04108.
    PubMed     Abstract available


  50. TAKANO-KAWABE K, Matoba K, Nakamura Y, Moriyama M, et al
    Low Density Lipoprotein Receptor-related Protein 2 Expression and Function in Cultured Astrocytes and Microglia.
    Neurochem Res. 2024;49:199-211.
    PubMed     Abstract available


  51. NADERI S, Motamedi F, Pourbadie HG, Rafiei S, et al
    Neuroprotective Effects of Ferrostatin and Necrostatin Against Entorhinal Amyloidopathy-Induced Electrophysiological Alterations Mediated by voltage-gated Ca(2+) Channels in the Dentate Gyrus Granular Cells.
    Neurochem Res. 2024;49:99-116.
    PubMed     Abstract available


    November 2023
  52. ZHAN Q, Kong F, Shao S, Zhang B, et al
    Pathogenesis of Depression in Alzheimer's Disease.
    Neurochem Res. 2023 Nov 28. doi: 10.1007/s11064-023-04061.
    PubMed     Abstract available


    October 2023
  53. SASIDHARAN R, Mohanan R, Kukreti N, Raj P, et al
    MAO-B Inhibitor (2E)-3-(4-Bromophenyl)-1-(1H-indol-3-yl) prop-2-en-1-one as a Neuroprotective Agent Against Alzheimer's Disease.
    Neurochem Res. 2023 Oct 9. doi: 10.1007/s11064-023-04031.
    PubMed     Abstract available


    September 2023
  54. WU Z, Tang W, Ibrahim FEEM, Chen X, et al
    Abeta Induces Neuroinflammation and Microglial M1 Polarization via cGAS-STING-IFITM3 Signaling Pathway in BV-2 Cells.
    Neurochem Res. 2023;48:2881-2894.
    PubMed     Abstract available


  55. ASGHAR H, Ahmed T
    Comparative Study of Time-Dependent Aluminum Exposure and Post-Exposure Recovery Shows Better Improvement in Synaptic Changes and Neuronal Pathology in Rat Brain After Short-Term Exposure.
    Neurochem Res. 2023;48:2731-2753.
    PubMed     Abstract available


    August 2023
  56. PANG LW, Hamzah S, Tan SLJ, Mah SH, et al
    The Effects and Mechanisms of Xanthones in Alzheimer's Disease: A Systematic Review.
    Neurochem Res. 2023 Aug 14. doi: 10.1007/s11064-023-04005.
    PubMed     Abstract available


    May 2023
  57. ZHOU Y, Wang Y, Wang Y, Chen L, et al
    LncRNA NKILA Exacerbates Alzheimer's Disease Progression by Regulating the FOXA1-Mediated Transcription of TNFAIP1.
    Neurochem Res. 2023 May 23. doi: 10.1007/s11064-023-03944.
    PubMed     Abstract available


    April 2023
  58. SIDDIQUI N, Ali J, Parvez S, Najmi AK, et al
    Neuroprotective Role of DPP-4 Inhibitor Linagliptin Against Neurodegeneration, Neuronal Insulin Resistance and Neuroinflammation Induced by Intracerebroventricular Streptozotocin in Rat Model of Alzheimer's Disease.
    Neurochem Res. 2023 Apr 20. doi: 10.1007/s11064-023-03924.
    PubMed     Abstract available


  59. LIM D, Tapella L, Dematteis G, Talmon M, et al
    Calcineurin Signalling in Astrocytes: From Pathology to Physiology and Control of Neuronal Functions.
    Neurochem Res. 2023;48:1077-1090.
    PubMed     Abstract available


  60. HUFFELS CFM, Middeldorp J, Hol EM
    Ass Pathology and Neuron-Glia Interactions: A Synaptocentric View.
    Neurochem Res. 2023;48:1026-1046.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.